All Journals > Infection Control and Hospital Epidemiology > April 2007 > Healthcare‐Associated, Multidrug‐Resistant Tuberculosis in Austria

Article Tools

Search for Related Articles

  • By Author
  • Search In

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

April 2007

Volume 28, Number 4
Infect Control Hosp Epidemiol 2007;28:483–485
0899-823X/2007/2804-0019$15.00
DOI: 10.1086/513450
Concise Communication

A Case of Healthcare‐Associated, Multidrug‐Resistant Tuberculosis in Austria: Reconsidering the Value of Cohorting of Patients with Culture‐Positive Tuberculosis

Alexander Indra, MD;

Barbara Robl, MD;

Ingrid Aumüller, MD;

Eva Magnet, MD;

Stefan Meusburger, MD, MSc;

Franz Allerberger, MD, MPH

From the Austrian Agency for Health and Food Safety, Vienna (A.I., B.R., I.A., F.A.), and the Public Health Authority of the Province of Oberösterreich, Linz (E.M., S.M.), Austria.

Cohorting of patients with culture‐positive tuberculosis is still widely practiced in Austria, a country where approximately 1% of Mycobacterium tuberculosis isolates are multidrug resistant. Cohorting of patients with tuberculosis prior to determination of drug susceptibility is unacceptable because M. tuberculosis superinfection can occur.

Received May 3, 2006; accepted June 23, 2006; electronically published February 26, 2007.

Address reprint requests to Franz Allerberger, MD, Austrian Agency for Health and Food Safety, Spargelfeldstr. 191, A‐1220 Vienna, Austria ().
Close Popup